Application of induced pluripotent stem cell technology to the study of hematological diseases

Mailin Li, Pasquale Cascino, Simone Ummarino, Annalisa Di Ruscio

Risultato della ricerca: Contributo su rivistaArticolo di reviewpeer review

Abstract

The burst of reprogramming technology in recent years has revolutionized the field of stem cell biology, offering new opportunities for personalized, regenerative therapies. The direct reprogramming of somatic cells to induced pluripotent stem cells (iPSCs) has provided an invaluable tool to study and model a wide range of human diseases. Here, we review the transforming potential of such a strategy in research and in therapies applicable to the hematology field.

Lingua originaleInglese
Numero di articolo7
RivistaCells
Volume6
Numero di pubblicazione1
DOI
Stato di pubblicazionePubblicato - 8 mar 2017
Pubblicato esternamente

Fingerprint

Entra nei temi di ricerca di 'Application of induced pluripotent stem cell technology to the study of hematological diseases'. Insieme formano una fingerprint unica.

Cita questo